MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Magnetic resonance imaging(MRI)"

  • 2023 International Congress

    Diagnostic accuracy of susceptibility map-weighted MRI for discriminating tremor-dominant Parkinson’s disease and essential tremor

    MK. Yoon, S. Jo, S. Lee, J. Lee, CH. Suh, SJ. Chung (Seoul, Republic of Korea)

    Objective: We investigated the diagnostic accuracy of nigrosome using susceptibility map-weighted imaging (SMwI) in distinguishing tremor-dominant Parkinson's disease (PD) and essential tremor (ET). Background: Tremor is…
  • 2023 International Congress

    Hemibody dystonia secondary to Neurobehçet disease : a case report

    S. Saaf, Z. El Yacoubi, S. Lhassani, Y. Mimouni, M. Hakimi, M. El Azhari, A. Hazim, J. Aasfara, H. Ouhabi (casablanca, Morocco)

    Objective: To report the case of a patient who presented with dystonia  secondary to an inflammatory lesion of the putamen Background: Behçet’s Disease is a multisystemic…
  • 2023 International Congress

    Diffusion imaging study of mild behavioral impairment in Parkinson’s disease.

    H. Almgren, M. Descoteaux, M. Ghahremani, Z. Ismail, O. Monchi (Calgary, Canada)

    Objective: Patients with Parkinson’s disease (PD) experience changes in behavior, personality, and cognition. Mild Behavioral Impairment (MBI) is a validated neurobehavioral syndrome that identifies a…
  • 2023 International Congress

    MRI morphometry and regional hypometabolism in the clinical predominance-types of Progressive Supranuclear Palsy

    H. Chovatiya, K. Pillai, R. Kamble, S. Santhamma, P. Rajeswari, M. Chacko, A. Kishore (Kochi, India)

    Objective: To compare brain MRI morphometry and regional hypometabolism among the clinical predominance-types of Progressive Supranuclear Palsy. Background: Recently, MDS-PSP criteria for the clinical diagnosis…
  • 2023 International Congress

    No laughing white matter: reduced integrity of the lateral nucleus basalis of Meynert pathway in Parkinson’s disease-related cognitive impairment

    R. Crockett, K. Wilkins, S. Aditham, H. Bronte-Stewart (Stanford, USA)

    Objective: Investigate differences in white matter integrity of the nucleus basalis of Meynert (NBM) tracts in Parkinson’s disease (PD) patients who develop mild cognitive impairment…
  • 2023 International Congress

    Cerebellar volumetry in SCA1, SCA3, SCA6, MSA-C, and SAOA

    M. Ferreira, T. Schaprian, T. Klockgether, J. Faber (Bonn, Germany)

    Objective: We aim to identify volume differences in the cerebellum between spinocerebellar ataxia type 1 (SCA1), SCA3, SCA6, multiple-system atrophy, cerebellar type (MSA-C), and sporadic…
  • 2023 International Congress

    Post encephalitic dystonia-ataxia syndrome

    A. Elavarasi, F. Mustafa, A. Garg, M. Tripathi, D. Vibha, R. Singh, B. Mishra (New Delhi, India)

    Objective: To describe a young man with post encephalitc dystonia-ataxia with transient worsening following a febrile episode Background: We had a 19 year old young…
  • 2023 International Congress

    How helpful is the Swallow tail sign in Parkinson’s disease?

    M. Abu Al-Melh, N. Abdelall, T. Al-Otaibi (Ahmadi, Kuwait)

    Objective: To report a patient diagnosed with idiopathic Parkinson’s disease (PD) with an intact Swallow tail sign (STS) shown in his MR susceptibility-weighted imaging (SWI)…
  • 2023 International Congress

    Progressive cortical cerebrovascular reactivity reduction occurs in Parkinson’s disease: a longitudinal study

    LR. Jin (Shanghai, China)

    Objective: In the longitudinal study, we aimed to investigate regional cerebrovascular reactivity (CVR) changes in the patients with PD at baseline and during a 2-year…
  • 2023 International Congress

    Study protocol for the iMarkHD study in individuals with Huntington’s disease

    D. van Wamelen, T. Wood, M. Veronese, C. Ginestet, N. Martin, O. Makos, J. Badenoch, M. Hartmann, A. Rangel Cristales, E. Rabiner, R. Gunn, S. Tabrizi, A. Wood, S. Williams (London, United Kingdom)

    Objective: To describe the study protocol for the iMarkHD study. Background: Huntington’s disease (HD) is still often defined by the onset of motor symptoms, inversely…
  • « Previous Page
  • 1
  • …
  • 15
  • 16
  • 17
  • 18
  • 19
  • …
  • 72
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • #25179 (not found)
  • Screening and Treatment of Depression in Parkinson’s Disease within Movement Disorders Centers: A Quality Improvement Initiative
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • An atypical and interesting feature of Parkinson´s disease
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • DaTscan in clinical evaluation of Multiple System Atrophy
  • Decision-making process for opicapone’s bedtime regimen
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley